Gedeon Richter PLC
Gedeon Richter PLC researches, develops, manufactures, markets, and sells pharmaceutical products. The company offers women's healthcare products for contraceptives, endometriosis, fertility, menopause, vaginal infections, and uterine fibroids, as well as Femtech, a digital therapeutic solution to enhance women's lives. It also provides central nervous system products, such as products for the tr… Read more
Gedeon Richter PLC (0QFP) - Total Liabilities
Latest total liabilities as of September 2021: £249.71 Billion GBP
Based on the latest financial reports, Gedeon Richter PLC (0QFP) has total liabilities worth £249.71 Billion GBP as of September 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Gedeon Richter PLC - Total Liabilities Trend (2016–2020)
This chart illustrates how Gedeon Richter PLC's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Gedeon Richter PLC Competitors by Total Liabilities
The table below lists competitors of Gedeon Richter PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Taiwan Semiconductor Manufacturing
NYSE:TSM
|
USA | $2.47 Trillion |
|
MOL Hungarian Oil & Gas PLC
LSE:0RUK
|
UK | £3.55 Trillion |
|
Meta Platforms Inc.
NASDAQ:META
|
USA | $148.78 Billion |
|
Facebook Inc. Cl A
LSE:0QZI
|
UK | $148.78 Billion |
|
Tesla Inc
NASDAQ:TSLA
|
USA | $54.94 Billion |
|
Berkshire Hathaway Inc
NYSE:BRK-A
|
USA | $502.47 Billion |
|
Eli Lilly and Company
NYSE:LLY
|
USA | $91.08 Billion |
|
JPMorgan Chase & Co
NYSE:JPM
|
USA | $4.06 Trillion |
Liability Composition Analysis (2016–2020)
This chart breaks down Gedeon Richter PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.82 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.22 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Gedeon Richter PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Gedeon Richter PLC (2016–2020)
The table below shows the annual total liabilities of Gedeon Richter PLC from 2016 to 2020.
| Year | Total Liabilities | Change |
|---|---|---|
| 2020-12-31 | £141.63 Billion | +0.68% |
| 2019-12-31 | £140.67 Billion | +19.52% |
| 2018-12-31 | £117.70 Billion | +15.92% |
| 2017-12-31 | £101.54 Billion | -25.27% |
| 2016-12-31 | £135.88 Billion | -- |